What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cardiology
Pulmonary embolism, Internal medicine, Cardiology, Intensive care medicine and Surgery are his primary areas of study.
He interconnects Respiratory disease, Prospective cohort study, Thrombolysis and Embolism in the investigation of issues within Pulmonary embolism.
His Internal medicine study frequently links to adjacent areas such as Endocrinology.
His Intensive care medicine study incorporates themes from Heart Function Tests, Disease, MEDLINE and Acute decompensated heart failure.
His Retrospective cohort study, Embolectomy and Randomized controlled trial study in the realm of Surgery interacts with subjects such as Heart-type fatty acid binding protein.
His study in Heart failure is interdisciplinary in nature, drawing from both Cardiovascular agent and Transplantation.
His most cited work include:
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. (9345 citations)
- Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) (2467 citations)
- 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism (1754 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Pulmonary embolism, Cardiology, Intensive care medicine and Thrombosis.
Platelet is closely connected to Endocrinology in his research, which is encompassed under the umbrella topic of Internal medicine.
His Pulmonary embolism research includes themes of Odds ratio, Thrombolysis, Mortality rate and Risk stratification.
His research integrates issues of Decompensation, Fibrinolytic agent, Heparin and Cardiogenic shock in his study of Thrombolysis.
His studies link Blood pressure with Cardiology.
The study incorporates disciplines such as Venous thromboembolism, Randomized controlled trial, Disease and MEDLINE in addition to Intensive care medicine.
He most often published in these fields:
- Internal medicine (69.38%)
- Pulmonary embolism (64.61%)
- Cardiology (37.38%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (69.38%)
- Pulmonary embolism (64.61%)
- Cardiology (37.38%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Pulmonary embolism, Cardiology, Intensive care medicine and Thrombosis.
He merges many fields, such as Internal medicine and In patient, in his writings.
The various areas that Stavros Konstantinides examines in his Pulmonary embolism study include Odds ratio, Incidence, Mortality rate, Risk stratification and Cardiopulmonary resuscitation.
His work in Cardiology covers topics such as Adverse outcomes which are related to areas like Prognostic score.
His Intensive care medicine research incorporates elements of Heparin, MEDLINE and Antithrombotic.
His Thrombosis research is multidisciplinary, relying on both Gastroenterology, Prospective cohort study, Lung and Pathogenesis.
Between 2019 and 2021, his most popular works were:
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (1132 citations)
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS) (626 citations)
- Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. (90 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
His primary areas of study are Internal medicine, Pulmonary embolism, Thrombosis, Intensive care medicine and Cardiology.
In general Internal medicine study, his work on Interquartile range, Pulmonary hypertension and Hazard ratio often relates to the realm of In patient, thereby connecting several areas of interest.
His Pulmonary embolism research is multidisciplinary, incorporating perspectives in Mortality rate, Quality of life, Incidence and Cohort study.
As a part of the same scientific family, Stavros Konstantinides mostly works in the field of Thrombosis, focusing on Epidemiology and, on occasion, Platelet activation.
His research in the fields of Diagnosis management overlaps with other disciplines such as Pandemic.
Stavros Konstantinides combines subjects such as Guideline and Prospective cohort study with his study of Cardiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
